| Authors: |
Mocking TAM; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands., van Oostveen WM; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands.; Department of Rheumatology, Leiden University Medical Center, Leiden University, Leiden, Netherlands.; Immunology and Respiratory Diseases, Boehringer-Ingelheim, Ridgefield, CT, United States.; Oncode Institute, Leiden, Netherlands., van Veldhoven JPD; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands.; Department of Rheumatology, Leiden University Medical Center, Leiden University, Leiden, Netherlands.; Immunology and Respiratory Diseases, Boehringer-Ingelheim, Ridgefield, CT, United States.; Oncode Institute, Leiden, Netherlands., Minnee H; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands., Fehres CM; Department of Rheumatology, Leiden University Medical Center, Leiden University, Leiden, Netherlands., Whitehurst CE; Immunology and Respiratory Diseases, Boehringer-Ingelheim, Ridgefield, CT, United States., IJzerman AP; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands., Heitman LH; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands.; Oncode Institute, Leiden, Netherlands. |
